Pulmonx Operating Margin 2019-2025 | LUNG
Current and historical operating margin for Pulmonx (LUNG) over the last 10 years. The current operating profit margin for Pulmonx as of March 31, 2025 is -62.88%.
| Pulmonx Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.09B | $-0.06B | -65.91% |
| 2024-12-31 | $0.08B | $-0.06B | -69.05% |
| 2024-09-30 | $0.08B | $-0.06B | -74.68% |
| 2024-06-30 | $0.08B | $-0.06B | -77.92% |
| 2024-03-31 | $0.07B | $-0.06B | -82.19% |
| 2023-12-31 | $0.07B | $-0.06B | -88.41% |
| 2023-09-30 | $0.07B | $-0.06B | -95.38% |
| 2023-06-30 | $0.06B | $-0.06B | -100.00% |
| 2023-03-31 | $0.06B | $-0.06B | -101.72% |
| 2022-12-31 | $0.05B | $-0.06B | -109.26% |
| 2022-09-30 | $0.05B | $-0.06B | -105.66% |
| 2022-06-30 | $0.05B | $-0.05B | -100.00% |
| 2022-03-31 | $0.05B | $-0.05B | -102.00% |
| 2021-12-31 | $0.05B | $-0.05B | -97.92% |
| 2021-09-30 | $0.04B | $-0.04B | -100.00% |
| 2021-06-30 | $0.04B | $-0.04B | -92.86% |
| 2021-03-31 | $0.03B | $-0.04B | -111.76% |
| 2020-12-31 | $0.03B | $-0.03B | -94.12% |
| 2020-06-30 | $0.02B | $-0.02B | -100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.065B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.976B | 58.49 |
| Hims & Hers Health (HIMS) | United States | $14.001B | 145.47 |
| Doximity (DOCS) | United States | $10.768B | 49.85 |
| Tempus AI (TEM) | United States | $9.502B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.267B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.719B | 58.11 |
| Hinge Health (HNGE) | United States | $3.507B | 0.00 |
| Privia Health (PRVA) | United States | $2.299B | 157.17 |
| 10x Genomics (TXG) | United States | $1.611B | 0.00 |
| Phreesia (PHR) | United States | $1.567B | 0.00 |
| Azenta (AZTA) | United States | $1.481B | 68.81 |
| Enovis (ENOV) | United States | $1.470B | 8.20 |
| Schrodinger (SDGR) | United States | $1.433B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.415B | 0.00 |
| Omnicell (OMCL) | United States | $1.394B | 26.34 |
| Evolent Health (EVH) | United States | $1.172B | 99.80 |
| Claritev (CTEV) | United States | $0.632B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.564B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Talkspace (TALK) | United States | $0.387B | 115.50 |
| Butterfly Network (BFLY) | United States | $0.346B | 0.00 |
| TruBridge (TBRG) | United States | $0.309B | 684.67 |
| Outset Medical (OM) | United States | $0.267B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.249B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.245B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.188B | 0.00 |
| CapsoVision (CV) | United States | $0.181B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.076B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.073B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |